Immunoediting, neoantigen frequency, and clinical outcome in patients with ovarian clear cell carcinoma

被引：1
|
作者：
Hasegawa, K. [1 ]
Matsushita, H. [2 ]
Oda, K. [3 ]
Yamamoto, S. [4 ]
Nishijima, A. [3 ]
Imai, Y. [1 ]
Asada, K. [3 ]
Ikeda, Y. [1 ]
Fujiwara, K. [1 ]
Aburatani, H. [4 ]
Kakimi, K. [2 ]
机构：
[1] Saitama Med Univ Int Med Ctr, Hidaka, Japan
[2] Univ Tokyo Hosp, Tokyo, Japan
[3] Univ Tokyo, Tokyo, Japan
[4] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo, Japan
来源：
GYNECOLOGIC ONCOLOGY | 2017年 / 145卷
关键词：
D O I：
10.1016/j.ygyno.2017.03.039
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
12
引用
收藏
页码：7 / 8
页数：3
相关论文
共 50 条
  • [31] Patterns of recurrence and impact on survival in patients with clear cell ovarian carcinoma
    Hogen, Liat
    Vicus, Danielle
    Ferguson, Sarah Elizabeth
    Gien, Lilian T.
    Nofech-Mozes, Sharon
    Lennox, Genevieve K.
    Bernardini, Marcus Q.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 (07) : 1164 - 1169
  • [32] A NEW MARKER OF POOR OUTCOME AND POTENTIAL THERAPEUTIC TARGET IN OVARIAN CLEAR CELL CARCINOMA
    Hooper, J.
    He, Y.
    Wu, A.
    Harrington, B.
    Davies, C.
    Wallace, S.
    Gilks, B.
    Perrin, L.
    Armes, J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 958 - 959
  • [33] Molecular portraits of clear cell ovarian and endometrial carcinoma with comparison to clear cell renal cell carcinoma
    Ackroyd, Sarah A.
    Arguello, David
    Ramos, Pilar
    Mahdi, Haider
    ElNaggar, Adam
    Winer, Ira
    Holloway, Rob
    Krivak, Thomas
    Jones, Nathaniel
    Turner, Valerie Galvan
    Herzog, Thomas
    Chu, Christina
    Brown, Jubilee
    Mantia-Smaldone, Gina
    GYNECOLOGIC ONCOLOGY, 2023, 169 : 164 - 171
  • [34] Molecular portraits of clear cell ovarian and endometrial carcinoma with comparison to clear cell renal cell carcinoma
    Mantia-Smaldone, G. M.
    Arguello, D.
    Mahdi, H.
    ElNaggar, A. C.
    Winer, I.
    Holloway, R. W.
    Krivak, T. C.
    Jones, N. L.
    Galvan-Turner, V.
    Herzog, T. J.
    Chu, C.
    Brown, J.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 175 - 175
  • [35] The clinical significance of lymphocyte activation gene 3 for ovarian clear cell carcinoma
    Zaitsu, Sumika
    Yano, Mitsutake
    Adachi, Sawako
    Miwa, Maiko
    Katoh, Tomomi
    Kawano, Yasushi
    Yasuda, Masanori
    JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2022, 153
  • [36] IS THERE ANY DIFFERENCE BETWEEN CLINICAL BEHAVIOR OF OVARIAN AND UTERINE CLEAR CELL CARCINOMA?
    Seker, Z. B.
    Cetinkaya, N.
    Sirvan, L.
    Meydanli, M. M.
    Gungor, T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 1312 - 1312
  • [37] Clinical characteristics with patterns of relapse and survival analysis of ovarian clear cell carcinoma
    Kaur, S.
    Kerkar, R. A.
    Maheshwari, A.
    Shylasree, T. S.
    Gupta, S.
    Deodhar, K.
    INDIAN JOURNAL OF CANCER, 2016, 53 (02) : 288 - 291
  • [38] Clinical and molecular differences between clear cell and papillary serous ovarian carcinoma
    Eltabbakh, GH
    Mount, SL
    Beatty, B
    Simmons-Arnold, L
    Cooper, K
    JOURNAL OF SURGICAL ONCOLOGY, 2006, 93 (05) : 379 - 386
  • [39] A Rare Case of Metachronous Clear Cell Ovarian Carcinoma and Thyroid Carcinoma: Clinical and Pathological Insights
    Ridwan, Steven
    Harsono, Ali Budi
    Suardi, Dodi
    Kurniadi, Andi
    Mantilidewi, Kemala Isnainiasih
    Hidayat, Yudi Mulyana
    INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2025, 17 : 119 - 125
  • [40] Ovarian clear cell carcinoma in Cowden Syndrome
    Yauy, K.
    Imbert-Bouteille, M.
    Bubien, V.
    Lindet-Bourgeois, C.
    Rathat, G.
    Perrochia, H.
    MacGrogan, G.
    Bessis, D.
    Tinat, J.
    Baert-Desurmont, S.
    Blanluet, M.
    Vande Perre, P.
    Baudry, K.
    Pujol, P.
    Corsini, C.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1558 - 1559
12345